A 21-marker blood panel covering kidney, liver, lipid and blood sugar markers plus lipase, aimed at people taking daily injectable liraglutide (Saxenda) who want to monitor how their body is responding over time.
21 biomarkers as listed by Blue Horizon Medicals.
This panel groups together markers commonly used to keep an eye on how the body is coping with daily injectable GLP-1 therapy. The kidney markers (sodium, urea, chloride, eGFR and creatinine) are commonly used to assess hydration and kidney function, which can be relevant if gastrointestinal side effects affect fluid intake. The liver markers (total protein, albumin, globulin, ALP, ALT, AST, GGT and bilirubin) are commonly used to assess liver function; the lipid profile (total cholesterol, non-HDL, triglycerides, HDL and LDL) is commonly used to assess cardiovascular risk factors; HbA1c is used to assess longer-term blood sugar control; and lipase is commonly used to assess pancreatic health. The provider suggests a baseline test before your first dose, then a recheck every 3 months or whenever your dose changes.
This exact test has no comparison-group peers in our data, so it cannot be measured against named rivals directly. Set against the broader pool of metabolism tests we track, though, £129.75 lands only a little above the £124.38 median, and its 21 markers make it one of the deeper panels in that wider group. You give a venous blood sample at a clinic or via a nurse home visit, with results back in 5 days.
The strongest contributors to the score are clinical depth and clarity, thanks to the size of the panel and a listing that spells out the description, full biomarker list, sample type, turnaround and collection choices, though it stops short of describing the report format. Value for money sits in the middle rather than clearly ahead, since the price is a touch above the metabolism-test median. A doctor reviews the results, which helps the results and follow-up score, while the need for a venous draw rather than an at-home kit caps collection convenience.
This suits you if you are taking, or about to start, daily liraglutide injections and want a wide set of markers to track over time, ideally as a baseline before your first dose and then every 3 months or after a dose change. It is a broad panel, so it may include more than you need if you are only tracking one or two specific markers. There is no comparison group in our data for this exact test, so we cannot point you to a cheaper or deeper named alternative.
You give a venous blood sample, either at a clinic appointment or with a nurse home visit. The sample is sent to the lab and tested across kidney, liver, lipid, HbA1c and lipase markers, and a doctor reviews the results before they are returned to you. Results are provided within 5 days of your sample being received.
This 21-marker panel covers kidney, liver, lipid, HbA1c and lipase markers for £129.75, close to the £124.38 median for similarly sized metabolism tests we track. It is pitched at people taking daily liraglutide injections (Saxenda), with a baseline test suggested before starting and a recheck every 3 months or after a dose change. There is no comparison group of directly equivalent tests, so we cannot say how it compares with named rivals.
The listing publishes a detailed description, the full biomarker list, a stated turnaround, clear collection options, the sample type; it does not state what the report looks like.
21 biomarkers, placing it in the 78th percentile of metabolism tests we track.
A blood sample taken at home by a visiting nurse or phlebotomist; with a venous or clinic option as well; a home nurse visit is offered; results in around 5 days, in line with or faster than similar tests.
Results are reviewed by a doctor; the provider does not describe the report format.
Trustpilot 4.2 from 395 reviews; accredited lab (UKAS ISO 15189 partner labs); trading 17+ years.
£129.75 against a median of £124.38 for the 14 similarly sized metabolism tests we track (+4%).
Calculated 13 September 2026 from the facts we hold about this test and provider, using our published scoring formula. Scores are not hand-edited.
Mid-depth metabolic panel priced well below peers
Measures 19 markers of blood sugar, cholesterol, liver, kidney and inflammation to give a broad view of metabolic health.
Below-median price for a single-marker uric acid test
A single-marker blood test measuring uric acid, used to help monitor gout risk and related joint, kidney and metabolic health.
21-marker Dulaglutide monitoring panel
A 21-marker blood panel that checks kidney function, liver function, cholesterol, blood sugar (HbA1c) and pancreas health, aimed at people taking the GLP-1 medication Dulaglutide (Trulicity). Suits ongoing monitoring rather than a first general health check.
Wide 21-marker panel for ongoing Wegovy monitoring
This is a 21-marker blood panel covering kidney, liver, lipid and blood sugar markers, intended for people taking Wegovy (semaglutide) for weight management who want to monitor these systems over time. It suits ongoing monitoring rather than one-off screening.
